Demystifying Medicine Video

This video presents an overview of multiple sclerosis, molecular mechanisms, symptoms, methods of diagnosis, treatment and future research directions.

[Please complete our feedback form]

  • Baecher, A,C.,Kaskow, B., Howard L. (2018). Multiple Sclerosis: Mechanisms and Immunotherapy. Cell Press, 97(4), 742-768.
  • Didonna, A., & Oksenberg, J. R. (2017). The genetics of multiple sclerosis. In Multiple Sclerosis: Perspectives in Treatment and Pathogenesis [Internet]. Codon Publications.
  • Gaitán, M. I., & Correale, J. (2019). Multiple Sclerosis Misdiagnosis: a persistent problem to solve. Frontiers in neurology, 10, 466.
  • Gilmour, H., Ramage-Morin, P. L., & Wong, S. L. (2018). Multiple sclerosis: Prevalence and impact. Health Rep, 29(1), 3-8.
  • Handel, A. E., Handunnetthi, L., Giovannoni, G., Ebers, G. C., & Ramagopalan, S. V. (2010). Genetic and environmental factors and the distribution of multiple sclerosis in Europe. European Journal of Neurology, 17(9), 1210-1214.)
  • Lassmann, H., Horssen, J. (2011). The molecular basis of neurodegeneration in multiple sclerosis. FEBS Letters, 528(23), 3715–3723.
  • Kingwell, E., Marriott, J. J., Jetté, N., Pringsheim, T., Makhani, N., Morrow, S. A., ... & Dykeman, J. (2013). Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC neurology, 13(1), 128.)
  • Other Conditions to Rule Out. (n.d) National Multiple Sclerosis Society.

Accessibility for Ontarians With Disabilities Act (AODA)


The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at